Researchers sampled 197 reusable sharps containers for C. diff at processing facilities. The containers had high C. diff densities to allow researchers to investigate the efficacy of automated decontamination. Additionally, they sampled 50 reusable and 50 disposable sharps containers in C. diff patient rooms in seven hospitals.
The study shows C. diff spores were found on nine of the 197 reusable sharps containers prior to processing. The automated decontamination processing completely removed the C. diff spores.
In C. diff patient rooms, 8 percent of the reusable sharps containers and 16 percent of the disposable sharps containers had secondary infection counts of C. diff.
“With C. difficile bioburden being sub-infective on both [disposable sharps containers] and [reusable sharps containers], sharps containers being no-touch and glove removal required after sharps disposal, we found two links in the chain of infection to be broken and five of seven tests of evidence to be unmet,” study authors concluded.
More articles on healthcare quality:
Patients in warmer climates face higher risk of drug-resistant infections
Hospital opioid shortage could leave terminal patients in pain, cancer physician says
Increasing surveillance reduces mean MRSA NICU colonization duration by 246 hours
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.